JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,761,000 | +367.1% | 201,746 | +78.1% | 0.05% | +444.4% |
Q3 2019 | $377,000 | -45.0% | 113,248 | -18.1% | 0.01% | -40.0% |
Q2 2019 | $685,000 | -14.9% | 138,330 | +6.6% | 0.02% | -16.7% |
Q1 2019 | $805,000 | +466.9% | 129,789 | +207.3% | 0.02% | +350.0% |
Q4 2018 | $142,000 | -85.3% | 42,231 | -42.4% | 0.00% | -81.0% |
Q4 2017 | $966,000 | +4.2% | 73,311 | +23.1% | 0.02% | +16.7% |
Q3 2017 | $927,000 | +24.1% | 59,540 | +11.9% | 0.02% | +20.0% |
Q2 2017 | $747,000 | – | 53,212 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |